Abstract
The I1307K polymorphism in APC has been found to predispose to colorectal cancer in Ashkenazi Jews, and has recently been associated with an increased risk for breast cancer in the same population. In that study, we genotyped 205 paraffin-embedded breast cancers from Ashkenazi Jewish women diagnosed below the age of 65. We now present an extended analysis, with clinicopathological correlations between carriers of I1307K and non-carriers. Twenty-four of 209 cases (11.5%, 95% confidence interval 7.5–16.6) were found to carry the I1307K polymorphism. When stratifying the data by other relevant clinicopathological variables, we observed no association between the presence of this polymorphism and age at diagnosis (P = 0.52), grade (P = 0.074), tumour size (P = 0.99), lymph node status (P = 0.82), oestrogen receptor status (P = 0.23) or P53 immunoreactivity (P = 0.80). The breast-cancer specific 5-year survival for women with I1307 K polymorphism was 88.9% compared with 81.6% in women without I1307K (P = 0.34). Using microdissected samples and direct sequencing, no somatic mutations were observed in any of the 24 I1307K-positive cases. Single-strand conformation analysis of 158 of the I1307K-negative breast cancers that were available for study revealed no mobility shifts. We conclude that the presence of the I1307K polymorphism does not appear to be associated with any particular clinicopathological feature of breast cancer and importantly, does not affect the prognosis.
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Devilee, P & Cornelisse, CJ (1994) Somatic genetic changes in human breast cancer. Biochim Biophys Acta 1198: 113–130.
Gryfe, R, Di Nicola, N, Gallinger, S & Redston, M (1998) Somatic instability of the APC I1307K allele in colorectal neoplasia. Cancer Res 58: 4040–4043.
Gryfe, R, Di Nicola, N, Lal, G, Gallinger, S & Redston, M (1999) Inherited colorectal polyposis and cancer risk of the APC I1307K Polymorphism. Am J Hum Genet 64: 378–384.
Karp, S, Tonin, PN, Begin, LR, Martinez, JJ, Zhang, JC, Pollak, MN & Foulkes, WD (1997) Influence of BRCA1 mutations on nuclear grade and estrogen receptor status of breast cancers in Ashkenazi Jewish women. Cancer 80: 435–441.
Laken, SJ, Petersen, GM, Gruber, SB, Oddoux, C, Ostrer, H, Giardiello, FM, Hamilton, SR, Hampel, H, Markowitz, A, Klimstra, D, Jhanwar, S, Winawer, S, Offit, K, Luce, MC, Kinzler, KW & Vogelstein, B (1997) Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC. Nature Genet 17: 79–83.
Lynch, HT, Smyrk, TC, Watson, P, Lanspa, SJ, Lynch, JF, Lynch, PM, Cavalieri, RJ & Boland, CR (1993) Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer: an updated review. Gastroenterology 104: 1535–1549.
Medeiros, AC, Nagai, MA, Neto, MM & Brentani, RR (1994) Loss of heterozygosity affecting the APC and MCC genetic loci in patients with primary breast carcinomas. Cancer Epidemiol Biomark Prevent 3: 331–333.
Moser, AR, Luongo, C, Gould, KA, McNeley, MK, Shoemaker, AR & Dove, WF (1995) ApcMin: a mouse model for intestinal and mammary tumorigenesis. Eur J Cancer 31A: 1061–1064.
Petrukhin, L, Dangel, JE, Vanderveer, L, Costalas, J, Bellacosa, A, Grana, G, Daly, M & Godwin, AK (1997) The I1307K APC mutation does not predispose to colorectal cancer in Jewish Ashkenazi breast and breast-ovarian cancer kindreds. Cancer Res 57: 5480–5484.
Redston, M, Nathanson, KL, Yuan, ZQ, Neuhausen, SL, Satagopan, J, Wong, N, Yang, D, Nafa, D, Abrahamson, J & Oczelik, H (1998) The APC I1307K allele and breast cancer risk. Nature Genet 20: 13–14.
Smith, KJ, Johnson, KA, Bryan, TM, Hill, DE, Markowitz, S, Willson, JK, Paraskeva, C, Petersen, GM, Hamilton, SR & Vogelstein, B et al (1993) The APC gene product in normal and tumor cells. Proc Natl Acad Sci USA 90: 2846–2850.
Thompson, AM, Morris, RG, Wallace, M, Wyllie, AH, Steel, CM & Carter, DC (1993) Allele loss from 5q21 (APC/MCC) and 18q21 (DCC) and DCC mRNA expression in breast cancer. Br J Cancer 68: 64–68.
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Yuan, Z., Bégin, L., Wong, N. et al. The effect of the I1307K APC polymorphism on the clinicopathological features and natural history of breast cancer. Br J Cancer 81, 850–854 (1999). https://doi.org/10.1038/sj.bjc.6690775
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bjc.6690775
Keywords
This article is cited by
-
Vascular proliferation is increased in basal-like breast cancer
Breast Cancer Research and Treatment (2011)
-
Glomeruloid microvascular proliferation is associated with p53 expression, germline BRCA1 mutations and an adverse outcome following breast cancer
British Journal of Cancer (2003)